MCCALL MILLER: Open Payments
NPI 1144838897 · CEDAR CITY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$424 in 16 payments from 11 companies in 2025. Trend: 2023 $190 · 2024 $427 · 2025 $424
Food & beverage: $424
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 3 | $155 |
| Janssen Biotech, Inc. | 2 | $48 |
| Organon LLC | 3 | $47 |
| Regeneron Healthcare Solutions, Inc. | 1 | $33 |
| LEO Pharma Inc. | 1 | $32 |
| Novartis Pharmaceuticals Corporation | 1 | $28 |
| Biofrontera Inc. | 1 | $21 |
| ABBVIE INC. | 1 | $20 |
| STRATA Skin Sciences, Inc. | 1 | $18 |
| Botanix SB Inc | 1 | $15 |
Products named: OTEZLA, TREMFYA, VTAMA, DUPIXENT, ADBRY, COSENTYX, SKYRIZI, XTRAC.
Industry payments across UT — which companies pay providers there.
